Month: December 2020

REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG), a pioneer in providing minimally invasive treatment for patients with severe lung disease, welcomes Georgia Garinois-Melenikiotou and Thomas W. Burns to its Board of Directors. Both Directors joined the Pulmonx Board in October 2020 in connection with Pulmonx’s initial public offering. Ms. Garinois-Melenikiotou brings a wealth of expertise in global consumer marketing, as well as broad corporate management experience through various senior leadership roles at multinational companies, including Estée Lauder and Johnson & Johnson. Mr. Burns brings extensive leadership and management experience in the medical technology industry and is currently the President, Chief Executive Officer and a member of the board of directors of Glaukos Corporation.  Georgia...

PCEX Futures contract is a virtual derivative contract that is quoted and settled in C2USD and each contract has a face value of a fixed amount of digital currencies. By introducing futures contracts in lot sizes, PCEX Member becomes the only cryptocurrency exchange in the world that enables traders or investors to buy numbers of contracts in one transaction. Moreover, it becomes the only cryptocurrency exchange in India that works on the NSE or BSE model and enables users to book maximum profit in the futures market at the lowest investment. The exchange provides a wider derivative portfolio with greater varieties of lot sizes in the C2USD market to cater to traders of all levels. From mini BTC contracts to FCC contracts of a lot size of 500, all contracts are available with up to 30x leverage levels. C2USD pairs on PCEX Member include...

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) — NEOVOLTA INC. (OTCQB: NEOV) – NeoVolta, manufacturer of Smart Energy Storage Systems, has received a total of $902,000 in purchase orders from PMP Energy. The most recent is a reorder of $425,000. This purchase order is part of a three-year exclusive distribution agreement signed earlier in 2020. In exchange for a minimum of up to $15 million in purchase orders, PMP Energy will provide dealers with training and certification to install NeoVolta systems in homes and other locations. To date they have trained and certified installers in four states plus the territory of Puerto Rico.This latest order follows an initial purchase order from PMP Energy for $473,000, which was announced on September 1. According to Dan Briggs, PMP Energy’s President and CEO, “This is the first reorder of what...

VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSXV: BBB) (the “Company” or “Brixton”) is pleased to announce the initial drill results from its fall/winter exploration program on the Langis Mine Project located in the Cobalt Camp of Ontario. The Company has received assays for the first 17 holes totaling 1624m of NQ size core. Approximately 6,000m of the 20,000m planned fall/winter drilling campaign have been completed. Drill holes follow a fan-type array with depths ranging from 52.5m to 148.4m across the main trend.HighlightsHole LM20-93 intercepted three mineralized intervals near surface, including:      • 6m of 193 g/t Ag from 2.6m; including 3m of 351 g/t Ag, including 1m of 990 g/t Ag     • 4m of 127 g/t Ag from 17.6m, including 2m of 238 g/t Ag     • 3m of 647 g/t Ag from 32.6m...

DALLAS, Dec. 08, 2020 (GLOBE NEWSWIRE) — Capital Senior Living Corporation (the “Company”) (NYSE: CSU) announced it has completed the operational transfer of its independent living community in Deer Park, Texas, to Fannie Mae, the holder of the community’s non-recourse debt. The Deer Park community is the first of 18 properties (the “Transition Communities”) the Company will transition to Fannie Mae under a cooperative process initiated in August, 2020.As previously announced, the Company plans to enhance liquidity and improve operating cash flow by eliminating underperforming operations and focusing on its core owned and managed portfolio. The Company will transfer the operations and ownership of the 18 Transition Communities, all of which are either underperforming or are in underperforming loan pools, to Fannie Mae. The Company...

HPN424 has shown confirmed partial response in treatment of metastatic castration–resistant prostate cancer in highest fixed dose cohort (160 ng/kg) of continuing Phase 1/2a dose escalation trialThree of seven patients in highest fixed dose HPN424 cohort have shown PSA reductionDose escalation trials advancing for HPN536 and HPN217 with initial data readouts and initiation of expansion cohorts expected in 2021Management to host clinical update webcast/call today, December 8, 2020, at 8 a.m. ETSOUTH SAN FRANCISCO, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) —  Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today provided a pipeline update and reported a confirmed partial response based on RECIST v1.1 criteria for its most advanced program, HPN424 for...

Stem to Launch 12 New Products in January Featuring, Cannabis-Infused Topicals, and a new CBD Product Line-Up from Patent Edibles -Pending Hemp GeneticsAcquisition of Driven Deliveries to Support Distribution DriveBOCA RATON, FL, Dec. 08, 2020 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (OTCQX: STMH CSE:STEM), a leading vertically-integrated cannabis and hemp branded products company with state-of-the-art cultivation, processing, extraction, retail, and distribution operations throughout the United States, announced that they will be starting 2021 with an exciting line-up of disruptive products beginning in Oregon and launching in all markets in which Stem operates. Stem has added a cutting-edge extraction laboratory to its commercial kitchen capabilities for full integration in production of these value-added, margin-accretive products....

GAITHERSBURG, Md., Dec. 08, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has commenced dosing in a Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical study of ALT-801. ALT-801 is a long-acting GLP-1/glucagon receptor dual agonist being developed for the treatment of non-alcoholic steatohepatitis (NASH), which is expected to affect more than 13 million adults in the United States.The Phase 1 clinical trial is being conducted in Australia and is expected to enroll approximately 50 and 60 volunteers in the SAD and MAD phases of the trial, respectively. The trial is designed to evaluate the safety, pharmacokinetics and activity of ALT-801 over 6 weeks of treatment in overweight and obese but otherwise normal volunteers. Readouts...

NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATON INTO THE USAVANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) — Independence Gold Corp. (TSX.V: IGO) (the “Company”) wishes to announce a proposed equity financing (the “Financing”) comprised of 6,250,000 flow-through common shares (the “FT Shares”) at a price of $0.16 per FT Share, for aggregate proceeds of $1,000,000; and 3,571,428 additional common shares (each a “Unit”) at a price of $0.14 per Unit for aggregate proceeds of $500,000. Each Unit will consist of one common share of the Company (a “Share”) and one half of one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one additional Share at an exercise price of $0.20 per common share for a period of 24 months. Subject to compliance with applicable...